Medicare Enrolled

Dr. Ferrol Lee, M.D.

Endocrinology · Sayre, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
317 W LOCKHART ST, Sayre, PA 18840
5708885858
In practice since 2006 (20 years)
NPI: 1356312151 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lee

Dr. Ferrol Lee is an endocrinology specialist in Sayre, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 3,520 Medicare services across 1,193 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lee received a total of $16,323 from 34 pharmaceutical and/or device companies across 226 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 10% volume in PA $16,323 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,520
Medicare services
Top 10% in PA for endocrinology
1,193
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~176 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,740 $18 $55
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
461 $87 $277
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
229 $8 $17
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
218 $9 $59
Diabetes self-management training, individual
Individualized education and training for managing diabetes, billed per 30-minute session.
184 $38 $136
Nursing facility visit, moderate complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes.
164 $81 $186
Principal care management for high-risk disease, first 30 minutes
This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month.
156 $62 $163
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
117 $59 $188
Nursing facility visit, high complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes.
99 $115 $273
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
47 $112 $410
Initial nursing facility care, high complexity
An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes.
31 $140 $336
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
23 $10 $64
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
21 $50 $182
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
18 $100 $303
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
12 $102 $330
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,323
Total received (2018-2024)
Avg $2,332/year across 7 years
Top 18% in PA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
226
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,847 (78.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,476 (21.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$958
2023
$495
2022
$758
2021
$513
2020
$328
2019
$409
2018
$12,861

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$272
Dexcom, Inc.
$161
Ascensia Diabetes Care Us Inc.
$74
Xeris Pharmaceuticals, Inc.
$69
Amneal Pharmaceuticals LLC
$51
RECORDATI_RARE_DISEASES_INC.
$47
SANOFI-AVENTIS U.S. LLC
$41
Novo Nordisk Inc
$40
Medtronic, Inc.
$31
Kyowa Kirin, Inc.
$29
Tandem Diabetes Care, Inc.
$22
AstraZeneca Pharmaceuticals LP
$21
ABBVIE INC.
$18
Bayer Healthcare Pharmaceuticals Inc.
$18
BETA BIONICS, INC.
$17
Amphastar Pharmaceuticals, Inc.
$16
Amgen Inc.
$16
CeQur Corporation
$14
Top 3 companies account for 52.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$12,754
Lilly USA, LLC
$575
SANOFI-AVENTIS U.S. LLC
$379
Dexcom, Inc.
$275
Novo Nordisk Inc
$244
Tandem Diabetes Care, Inc.
$242
AstraZeneca Pharmaceuticals LP
$181
Xeris Pharmaceuticals, Inc.
$175
Boehringer Ingelheim Pharmaceuticals, Inc.
$160
Medtronic, Inc.
$148
Insulet Corporation
$137
Janssen Biotech, Inc.
$124
GENZYME CORPORATION
$110
Amgen Inc.
$98
Ascensia Diabetes Care Us Inc.
$97
Senseonics, Incorporated
$79
Kyowa Kirin, Inc.
$59
DEXCOM, INC.
$57
Amneal Pharmaceuticals LLC
$51
RECORDATI_RARE_DISEASES_INC.
$47
Medtronic MiniMed, Inc.
$45
ABBVIE INC.
$38
Corcept Therapeutics
$35
Radius Health, Inc.
$34
Valeritas, Inc.
$34
Companion Medical, Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$18
BETA BIONICS, INC.
$17
CeQur Corporation
$17
Ascensia Diabetes Care US Inc.
$17
Amphastar Pharmaceuticals, Inc.
$16
Ultragenyx Pharmaceutical Inc.
$16
PFIZER INC.
$14
Becton, Dickinson and Company
$12
Top 3 companies account for 84.0% of all-time payments
Associated products mentioned in payments ›
ABIRATERONE ACETATE TABLETS · BAQSIMI · BD Nano · CeQur Simplicity · Crysvita · Cryvista · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · Erleada · Eversense · FARXIGA · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INVOKANA · InPen · JARDIANCE · Kerendia · Korlym · LYUMJEV · MINIMED 780G · MOUNJARO · Minimed 670G System · Omnipod · Ozempic · RECORLEV · RYBELSUS · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMAVERT · SYNTHROID · TOUJEO · TRULICITY · TZIELD · Tymlos · UNITHROID · V-GO · ZYTIGA · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware.

Looking for an endocrinology specialist in Sayre?
Compare endocrinologists in the Sayre area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
7
Per 100K population
11.7
County median income
$62,482
Nearest hospital
ROBERT PACKER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lee is a clinical cardiology specialist, with above-average Medicare volume (top 10% in PA), with speaking/promotional industry engagement in the top 18% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lee experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lee performed 1,740 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $16,323 from 34 companies across 226 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other endocrinologists in Sayre?
Dr. Lee's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →